Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Overexpression of metallothionein confers resistance to anticancer drugs
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Overexpression of metallothionein confers resistance to anticancer drugs'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Overexpression
100%
Metallothionein
100%
Anticancer Drugs
100%
Cis-diamminedichloroplatinum
60%
Chlorambucil
60%
Melphalan
60%
Antineoplastic Agents
40%
Tumor Cell Lines
20%
Human Carcinoma Cells
20%
5-fluorouracil (5-FU)
20%
Acquired Resistance
20%
Chronic Exposure
20%
Heavy Metals
20%
Cross-resistance
20%
Alkylating Agents
20%
Resistance Mechanisms
20%
Virus Vector
20%
Bovine Papillomavirus
20%
DNA Encoding
20%
Clinically Significant
20%
Curative Treatment
20%
Pharmacology, Toxicology and Pharmaceutical Science
Metallothionein
100%
Anticancer Drug
100%
Cisplatin
75%
Chlorambucil
75%
Melphalan
75%
Malignant Neoplasm
25%
Anticarcinogen
25%
Papillomaviridae
25%
Cross-Resistance
25%
Metallothionein II
25%
Neoplasm
25%
Fluorouracil
25%
Carcinoma
25%
Heavy Metal
25%
Vincristine
25%
Alkylating Agent
25%
Long Term Exposure
25%
Antineoplastic Agent
25%
Medicine and Dentistry
Antineoplastic Agent
25%